Menopause & HRTPart of Menopause & HRTUpdated April 202613 min read

Low Estrogen Symptoms: The Complete Guide for Women

Low estrogen affects nearly every system — from hot flashes and brain fog to weight gain, low libido, and bone loss. Here's how to recognize the symptoms, find the cause, and restore hormonal balance.

Estrogen is not just a reproductive hormone. It is a systemic signaling molecule with receptors in the brain, heart, bones, skin, gut, joints, and urogenital tract. When estrogen levels drop — whether from perimenopause, primary ovarian insufficiency, surgical menopause, or other causes — the effects ripple through every one of those systems. That is why low estrogen produces such a bewildering array of symptoms, and why women experiencing them are so often misdiagnosed or told their complaints are “just stress.”

This guide covers the full symptom picture of low estrogen, the common and uncommon causes, how it is diagnosed, and what actually works for treatment. If you've been dismissed by a provider who couldn't connect the dots between your fatigue, your weight gain, your sleep problems, and your mood — this article will help you build the clinical case for a comprehensive evaluation.

What estrogen does in the body

Estrogen is the umbrella term for a family of steroid hormones produced primarily by the ovaries, with smaller contributions from the adrenal glands, adipose tissue, and (in men) the testes. The three main forms are:

Estradiol (E2), the dominant and most potent estrogen in reproductive-age women. This is what most lab tests measure and what most treatment approaches target.

Estrone (E1), the primary estrogen after menopause, produced largely by aromatization of androgens in adipose tissue.

Estriol (E3), produced in large quantities during pregnancy by the placenta, weaker than estradiol.

Estrogen receptors (ERα and ERβ) are expressed throughout the body. Estrogen supports bone density by inhibiting osteoclast activity. It maintains vaginal and urinary tract tissue. It influences serotonin, dopamine, and GABA systems in the brain, affecting mood and cognition. It supports cardiovascular health through effects on lipid profiles, vascular endothelium, and inflammation. It influences glucose metabolism and insulin sensitivity. It regulates fat distribution, favoring hip and thigh storage over visceral abdominal fat. It contributes to skin collagen, hair follicle health, and joint cartilage integrity.

When estrogen declines, all of these systems feel it simultaneously. That is why the symptom list is so extensive.

Symptoms of low estrogen

Organizing symptoms by body system clarifies why low estrogen affects so much of life and makes the clinical picture easier to recognize.

Vasomotor symptoms

Hot flashes and night sweats are the classic signature of estrogen decline. They affect 60 to 80 percent of women during the menopausal transition and can persist for years — some women experience them for a decade or more. The mechanism involves disruption of hypothalamic thermoregulation. KNDy neurons in the hypothalamus become dysregulated when estrogen is low, triggering inappropriate heat-dissipation responses.

Hot flashes typically begin in the chest and spread upward, last 1 to 5 minutes, and may be accompanied by flushing, sweating, rapid heartbeat, and occasionally nausea or anxiety. Night sweats disrupt sleep architecture, compounding every other symptom through chronic sleep deprivation.

Menstrual and reproductive symptoms

Irregular periods are often the first noticeable sign. Cycles may become shorter, longer, or skip entirely. Flow may be heavier (due to unopposed estrogen in anovulatory cycles) or lighter. Eventually, periods stop altogether.

Infertility or difficulty conceiving is common as estrogen declines in women trying to conceive in their late 30s and early 40s.

Vaginal dryness, painful intercourse (dyspareunia), and decreased libido reflect direct effects of estrogen deficiency on urogenital tissue. The vaginal epithelium thins, loses elasticity, and produces less lubrication. These symptoms are highly responsive to low-dose vaginal estrogen.

Urinary symptoms

Urinary urgency, frequency, recurrent urinary tract infections, and stress incontinence are part of genitourinary syndrome of menopause (GSM). The urethra and bladder are estrogen-responsive tissues that atrophy when hormones decline.

Mood and cognitive symptoms

Depression, anxiety, and irritability are common with low estrogen. Estrogen directly influences serotonergic, dopaminergic, and GABAergic neurotransmission. Women with a history of premenstrual-related mood sensitivity or postpartum depression are at elevated risk of estrogen-sensitive mood disorders during perimenopause.

Brain fog, memory lapses, difficulty concentrating, and word-finding problems affect a majority of women during the menopausal transition. Our deeper dive into brain fog root causes covers the mechanisms in detail.

Sleep symptoms

Insomnia, difficulty falling or staying asleep, and early morning waking are reported by 40 to 60 percent of women with low estrogen. Causes include night sweats, reduced progesterone (which has sleep-promoting GABAergic effects), and direct effects of estrogen on sleep architecture and REM regulation. Our guide to hormonal insomnia walks through the options.

Metabolic and body composition symptoms

Weight gain, particularly around the abdomen, is a direct consequence of declining estrogen. The shift from hip-and-thigh fat to visceral abdominal fat occurs independent of caloric intake. See our breakdown of menopause belly and the hormonal causes of weight gain.

Insulin resistance worsens as estrogen declines, increasing the risk of type 2 diabetes.

Dyslipidemia— rising LDL cholesterol and triglycerides with falling HDL — is driven by estrogen's effects on hepatic lipid metabolism.

Musculoskeletal symptoms

Joint pain and muscle aches (arthralgia) affect up to 60 percent of perimenopausal women. Estrogen has anti-inflammatory effects and supports cartilage and connective tissue health.

Loss of muscle mass(sarcopenia) accelerates without estrogen's supportive signaling, reducing strength and metabolic rate.

Bone loss is one of the most serious consequences of chronic estrogen deficiency. Women can lose 10 to 20 percent of bone mineral density in the 5 to 7 years around the final menstrual period. This sets the stage for osteoporosis and fragility fractures.

Skin and hair symptoms

Dry skin, decreased elasticity, and slower wound healingreflect estrogen's role in collagen synthesis. Skin collagen declines approximately 30 percent in the first 5 years after menopause.

Hair thinning, particularly at the temples and crown, affects many women with low estrogen. The follicular growth phase shortens. Our article on hormonal hair loss covers the options.

Cardiovascular symptoms

Heart palpitations, particularly at night or during hot flashes, are common. Most are benign but should be evaluated if persistent.

Cardiovascular risk itself rises with chronic estrogen deficiency. Women in the decade after menopause face rapidly accelerating risk of coronary artery disease, and this transition window is consequential for long-term cardiovascular trajectory.

What causes low estrogen?

Estrogen deficiency has many causes beyond natural menopause. Identifying the underlying cause shapes treatment.

Perimenopause and menopause

The most common cause of low estrogen is the natural aging of the ovaries. Our comprehensive guide to perimenopause covers this transition in depth.

Primary ovarian insufficiency (POI)

POI is menopause before age 40. It affects approximately 1 percent of women and can occur spontaneously or be triggered by genetics (Turner syndrome, Fragile X premutation), autoimmune disease, chemotherapy or radiation, or surgical removal of the ovaries. POI requires more aggressive hormone replacement than natural menopause because these women will spend decades without endogenous estrogen and face elevated risks of osteoporosis, cardiovascular disease, and cognitive decline if untreated.

Surgical menopause

Bilateral oophorectomy (removal of both ovaries) causes abrupt, severe estrogen deficiency. Unlike the gradual transition of natural menopause, surgical menopause produces immediate onset of severe symptoms. HRT is almost always indicated.

Hypothalamic amenorrhea

Severely low body fat, eating disorders, excessive exercise (especially in endurance athletes), and chronic stress can suppress hypothalamic GnRH secretion, shutting down ovarian function. This is common in athletes and women with anorexia nervosa. Recovery of hormonal function follows restoration of adequate energy availability.

Pituitary and hypothalamic disorders

Prolactinomas (benign pituitary tumors), traumatic brain injury, and other causes of pituitary dysfunction can impair the signaling that drives ovarian estrogen production.

Medications

Aromatase inhibitors (letrozole, anastrozole, exemestane) used in breast cancer treatment block the conversion of androgens to estrogen, producing severe iatrogenic estrogen deficiency.

GnRH agonists (leuprolide) used for endometriosis, fibroids, and certain cancers suppress ovarian function.

Chemotherapy — particularly alkylating agents — can damage ovarian follicles permanently.

Other causes

Autoimmune oophoritis, Addison's disease, diabetes with poor control,hypothyroidism, and several genetic conditions can all contribute to low estrogen. A complete evaluation looks beyond the most common causes.

How low estrogen is diagnosed

Diagnosis combines symptom assessment with targeted lab testing. Neither alone is sufficient.

The clinical interview

A thorough history covers menstrual pattern, age of onset, reproductive history, family history of menopause, medications, exercise patterns, dietary intake, body weight changes, stress levels, and full symptom review. Many women find it useful to complete a structured symptom inventory before their appointment — our free perimenopause symptom quiz and menopause quiz generate organized summaries.

Laboratory testing

Estradiol is the direct measure of ovarian estrogen production. Values vary across the menstrual cycle in reproductive-age women. Consistently low levels (below 30 pg/mL) in a menopausal woman or persistently low levels in a reproductive-age woman suggest deficiency.

FSH rises when the pituitary tries to stimulate failing ovaries. FSH above 25 mIU/mL suggests ovarian insufficiency; above 40 mIU/mL is consistent with menopause.

LH typically rises with FSH.

AMH (anti-Müllerian hormone) is produced by small ovarian follicles and declines with ovarian aging. AMH below 0.5 ng/mL suggests imminent or established menopause.

Progesterone reflects ovulation. Mid-luteal progesterone below 3 ng/mL in a menstruating woman suggests anovulatory cycles.

Testosterone often declines alongside estrogen, contributing to libido and mood symptoms.

Thyroid function (TSH, free T4, free T3) and prolactin should be checked to rule out other causes of similar symptoms.

DEXA scan assesses bone density and is appropriate for women with prolonged estrogen deficiency or risk factors for osteoporosis.

Treatment options for low estrogen

Hormone replacement therapy (HRT)

HRT is the most effective intervention for moderate-to-severe symptoms of estrogen deficiency. The Menopause Society, the Endocrine Society, and the International Menopause Society all support HRT as first-line treatment for women under 60 or within 10 years of menopause who do not have contraindications.

Transdermal estradiol (patch, gel, or spray) is generally preferred over oral estrogen because it bypasses first-pass liver metabolism, avoiding increased clotting risk.

Oral estrogen remains an option for women without cardiovascular or clotting risk factors.

Progesterone is required for women with a uterus to protect the endometrium. Oral micronized progesterone is the preferred form, with secondary benefits including improved sleep.

Vaginal estrogen (cream, tablet, or ring) specifically targets urogenital symptoms with minimal systemic absorption. It is safe for most women, including many breast cancer survivors (with oncologist input).

Testosterone is increasingly prescribed for women at female-physiologic doses to address libido, fatigue, and cognitive symptoms. It is off-label in the U.S.

For the full cost picture, see our HRT cost breakdown. If you're not sure HRT is right for you, our signs you need HRT article helps frame the decision.

Non-hormonal prescription options

For women who cannot take HRT:

Fezolinetant (Veozah) is FDA-approved for vasomotor symptoms, targeting hypothalamic KNDy neurons without hormonal effects elsewhere.

SSRIs and SNRIs (paroxetine, venlafaxine, escitalopram) reduce hot flashes by 30 to 60 percent. Paroxetine (Brisdelle) is FDA-approved; others are used off-label.

Gabapentin reduces VMS and can improve sleep.

Ospemifene is a selective estrogen receptor modulator approved for moderate-to-severe dyspareunia.

Lifestyle interventions

Lifestyle approaches cannot replace estrogen, but they can meaningfully reduce symptom burden and address the secondary consequences of low estrogen (bone loss, metabolic changes, cardiovascular risk).

Resistance training preserves muscle mass, improves insulin sensitivity, supports bone density, and improves mood.

Adequate protein intake (1.2–1.6 g per kg body weight per day) supports muscle preservation.

Phytoestrogensfrom whole food sources (soy, flaxseed, legumes) provide mild estrogenic activity through the body's receptors. Clinical effects on symptoms are modest but not zero.

Stress management addresses the HPA axis dysregulation that worsens vasomotor symptoms. Chronic elevated cortisol amplifies hot flash frequency.

Sleep hygiene and CBT-I partially offset sleep disruption from night sweats.

Avoiding excessive alcohol, which worsens VMS, disrupts sleep, and increases breast cancer risk.

Low estrogen vs. estrogen dominance

It is common for women to experience symptoms that feel like low estrogen but are actually related to progesterone deficiency or relative estrogen excess (estrogen dominance). In early perimenopause, estrogen can transiently spike above premenopausal levels while progesterone falls from anovulatory cycles. The result: irritability, breast tenderness, heavy periods, bloating, and fluid retention — symptoms that look different from classic low-estrogen hot flashes and vaginal dryness but come from the same underlying ovarian transition.

Our article on estrogen dominance covers this pattern in detail. If your symptoms feel like a mix — hot flashes and heavy periods, brain fog and breast tenderness — you may be experiencing the full spectrum of perimenopausal estrogen fluctuation rather than consistent deficiency.

When to see a physician

Seek evaluation for low estrogen symptoms in any of these scenarios:

Seek a menopause-trained physician — ideally one certified by the Menopause Society (MSCP) — for complex cases, HRT candidacy review, or if your current provider is not adequately addressing your symptoms. Our directory of bioidentical hormone therapy providers is a starting point.

Frequently asked questions

What are the most common symptoms of low estrogen?

The most common symptoms include hot flashes and night sweats, irregular or absent periods, vaginal dryness, decreased libido, mood changes (irritability, anxiety, depression), sleep disturbances, brain fog, fatigue, weight gain (particularly abdominal), joint pain, thinning hair, dry skin, and urinary changes. Because estrogen receptors exist throughout the body, deficiency affects nearly every organ system.

What causes low estrogen in women?

The most common cause is perimenopause and menopause. Other causes include primary ovarian insufficiency (menopause before age 40), surgical removal of the ovaries, chemotherapy or radiation, eating disorders, excessive exercise, hypothalamic dysfunction, pituitary disorders, autoimmune conditions, genetic conditions like Turner syndrome, and certain medications including aromatase inhibitors.

How is low estrogen diagnosed?

Low estrogen is diagnosed through clinical symptoms plus blood testing. Key labs include estradiol, FSH (which rises when estrogen is low), LH, AMH, thyroid function, and prolactin. Normal estradiol levels vary across the cycle; values below 30 pg/mL or consistently low levels in a menopausal woman confirm deficiency.

Can low estrogen cause weight gain?

Yes. Estrogen supports insulin sensitivity, influences fat distribution (favoring hip/thigh over abdominal storage), and supports muscle mass. Its decline increases insulin resistance, shifts fat to the abdomen, reduces muscle mass, and impairs sleep (which further disrupts glucose metabolism). Typical weight gain during the menopausal transition is 5 to 15 pounds, concentrated in the midsection.

How can I increase my estrogen naturally?

Natural approaches include phytoestrogen-rich foods (soy, flaxseed, legumes), cruciferous vegetables that support healthy estrogen metabolism, adequate body fat, strength training, stress management, adequate sleep, and limiting alcohol. These approaches provide modest symptom relief but cannot replace lost estrogen. For moderate-to-severe symptoms, HRT is the most effective intervention.

When should I see a doctor about low estrogen?

See a physician if symptoms affect quality of life, if periods stop before age 45, if you have significant family history of early menopause or osteoporosis, if sexual health is affected, or if you are considering HRT. A menopause-trained physician can evaluate symptoms, order testing, and discuss treatment options including HRT, non-hormonal prescriptions, and lifestyle interventions.

Sources & References

  1. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause, 2022;29(7):767-794.
  2. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 2015;100(11):3975-4011.
  3. European Society of Human Reproduction and Embryology (ESHRE) Guideline Group on POI. ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction, 2016;31(5):926-937.
  4. Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. Journal of Clinical Endocrinology & Metabolism, 2021;106(1):1-15.
  5. Mehta J, Kling JM, Manson JE. Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts. Frontiers in Endocrinology, 2021;12:564781.
  6. Genazzani AR, Monteleone P, Giannini A, Simoncini T. Pharmacotherapy of Hormone Replacement Therapy During Menopause: Present and Future Perspectives. Drugs, 2021;81(12):1299-1317.
  7. Shifren JL, Gass ML. The North American Menopause Society recommendations for clinical care of midlife women. Menopause, 2014;21(10):1038-1062.
  8. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. Journal of Clinical Endocrinology & Metabolism, 2012;97(4):1159-1168.

Medical disclaimer

This article is for informational purposes only and has not been clinically reviewed. It does not constitute medical advice, diagnosis, or treatment. Always consult a licensed physician before making any medical decisions. Nuletic does not diagnose, treat, cure, or prevent any disease. Individual results vary. Meet our medical team.

ShareX / Twitter|LinkedIn|

More in Menopause & HRT

View all →

Get notified when Nuletic launches

Physician-supervised optimization. Launching 2026.

Join Waitlist
Join Waitlist